VRC-HIVDNA009-00-VP
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
AIDS VaccinesHIV InfectionsHIV Seronegativity
Phase 1
HIV-1 Vaccine Test in Uninfected Adult Volunteers
CompletedNCT00047931
Start: 2002-10-17End: 2009-05-05Target: 50Updated: 2017-07-02
Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults
CompletedNCT00071851
Start: 2003-12-31End: 2005-10-31Target: 180Updated: 2021-10-14
Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection
CompletedNCT00125099
End: 2007-09-30Updated: 2021-11-01
Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults
CompletedNCT00270218
Start: 2006-02-28End: 2007-08-31Updated: 2021-10-14
Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults
CompletedNCT00384787
Start: 2006-11-30End: 2012-12-31Updated: 2021-10-14
Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda
CompletedNCT01549470
End: 2006-03-31Updated: 2021-11-01